A high level of expression of pSTAT3-S727, with a sensitivity of 0.86 and specificity of 0.9, appears to be a promising biomarker for the differential diagnosis of CD30+ PTCL-NOS and ALK- ALCL. Here, ALK is linked to anaplastic large cell lymphoma.